This study examined how tumor-associated microglia/macrophages (TAMs) promote glioblastoma (GBM) invasion through lipid-mediated paracrine signaling, using single-cell transcriptomics, spatial lipidomics, and functional perturbation in mouse models and human GBM samples.
Invading GBM cells reprogram myeloid cells via CSF1R-PI3K signaling, triggering secretion of bioactive lipids (LPCs and LPAs); disrupting this myeloid-GBM axis reduced lipid secretion and suppressed invasion, with further constraint achieved by targeting downstream LPA receptor (LPAR) or YAP/TAZ signaling.
Findings are primarily preclinical (mouse models and ex vivo human samples), with no reported clinical trial data or patient survival outcomes; the context-dependency of LPAR vs. YAP/TAZ targeting is not fully characterized; sample sizes for human GBM cohorts are not specified in the abstract.
The CSF1R-PI3K–lipid axis in TAMs is a potential therapeutic target to reduce GBM invasion and improve the extent of surgical resection; LPAR antagonism or YAP/TAZ inhibition may be rational add-on strategies, though clinical validation is still needed.